The Just FDA-Approved Weight Loss Pill-Foundayo (Orforglipron)

On April 1, 2026, the FDA approved Foundayo (orforglipron) — Eli Lilly's once-daily weight loss pill and the first needle-free alternative to injectable GLP-1 medications like Wegovy, Zepbound, and Mounjaro. No weekly injections. No cold storage. No special prep. Just a tablet, once a day.

If you've been searching for a needle-free GLP-1 option, here's what you need to know about Foundayo and how to find out if it's right for you.

What Is Foundayo (Orforglipron)?

Foundayo is an oral GLP-1 (glucagon-like peptide-1) receptor agonist that mimics a hormone your body already makes — one that regulates hunger, slows digestion, and helps you feel full longer.

Unlike older GLP-1 injections, Foundayo is a small-molecule pill, not a peptide. This makes it easier for the body to absorb through the stomach without breaking down too early, which is why Foundayo skips many of the restrictions tied to earlier oral weight loss medications.

Why People Are Switching to Foundayo

Older oral GLP-1 medications come with strict rules: take on an empty stomach, first thing in the morning, then wait 30 minutes before eating or drinking. Foundayo eliminates these barriers:

• No fasting required — take it any time of day

• No food or water restrictions — absorption isn't affected either way

• No injections — ideal for anyone who avoids needles or travels frequently

This flexibility makes it easier to stay consistent with a weight loss plan and consistency is what drives results with any GLP-1 program.

How Much Weight Can You Lose?

Results come from Eli Lilly's ATTAIN clinical trial program, tracked over 72 weeks (about a year and a half):

Trial Finding	Result
Average weight loss (highest dose)	11–12.4% of total body weight
Participants losing 10%+ of body weight	50–65% of users
Other benefits observed	Improved blood pressure, cholesterol, and waist circumference

Many patients also report reduced "food noise" — the constant background thoughts about eating — making portion control feel more natural.

Side Effects to Know

Because Foundayo acts directly on the digestive system, the most common side effects appear early in treatment:

• Nausea

• Diarrhea

• Constipation

• Mild stomach discomfort

Providers typically start patients on a low dose (0.8 mg) and increase it every 30 days based on tolerance. Most symptoms ease within the first few weeks.

Like other GLP-1 medications, Foundayo carries a boxed warning for thyroid C-cell tumor risk observed in animal studies — a key reason GLP-1 treatment should always be medically supervised, not self-prescribed.